We previously showed that eliminating GLUT1 from PyMT-transformed primary mouse mammary epithelial cells prior to orthotopic injection prevented tumor formation when cells were implanted into immune-compromised mice [31]. The gene discussed is SLC2A1; the disease is neoplasm.